BMC Neuroscience, 2012 · DOI: 10.1186/1471-2202-13-57 · Published: June 6, 2012
This study investigates how vascular endothelial growth factor (VEGF) gene therapy affects the reinnervation of the musculocutaneous nerve (MCN) after nerve repair in rats. The distal stump of the rat's transected MCN was treated with a plasmid (phVEGF) to increase VEGF production, and then the nerve was reconnected using either end-to-end (ETE) or end-to-side (ETS) neurorrhaphy. The study found that increasing VEGF levels in the MCN stump improved the quality of nerve regeneration and functional recovery after both ETE and ETS neurorrhaphy.
VEGF gene therapy can enhance the quality of axon regeneration after nerve repair.
Improved axon regeneration leads to better functional recovery of muscles innervated by the repaired nerve.
The easy transfection method is important relative to possible clinical applications.